Current Report Filing (8-k)
March 24 2021 - 4:16PM
Edgar (US Regulatory)
ORACLE CORP false 0001341439 0001341439 2021-03-22 2021-03-22 0001341439 us-gaap:CommonStockMember 2021-03-22 2021-03-22 0001341439 orcl:SeniorNotesDueJuly2025Member 2021-03-22 2021-03-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 22, 2021
Oracle Corporation
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-35992
|
|
54-2185193
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
2300 Oracle Way, Austin, Texas 78741
(Address of principal executive offices) (Zip Code)
(737) 867-1000
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, par value $0.01 per share
3.125% senior notes due July 2025
|
|
ORCL
|
|
New York Stock Exchange
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Section 8-Other Events
Issuance of $15 Billion Aggregate Principal Amount of Notes
On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.
The Notes are being offered pursuant to Oracle’s Registration Statement on Form S-3 filed on March 11, 2021 (Reg. No. 333-254166), including the prospectus contained therein (the “Registration Statement”) and a related preliminary prospectus supplement dated March 22, 2021 and prospectus supplement dated March 22, 2021.
The material terms and conditions of the Notes are set forth in the Officers’ Certificate filed herewith as Exhibit 4.1 and incorporated by reference herein, in the Indenture filed as Exhibit 10.34 to the Current Report on Form 8-K filed by Oracle Systems Corporation on January 20, 2006, and in the First Supplemental Indenture filed as Exhibit 4.3 to the Registration Statement on Form S-3 filed by Oracle Corporation on May 10, 2007.
Section 9-Financial Statements and Exhibits
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits
2|3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
ORACLE CORPORATION
|
|
|
|
|
Dated: March 24, 2021
|
|
|
|
By:
|
|
/s/ Brian S. Higgins
|
|
|
|
|
Name:
|
|
Brian S. Higgins
|
|
|
|
|
Title:
|
|
Vice President, Associate General Counsel and
Secretary
|
3|3
Oracle (NYSE:ORCL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oracle (NYSE:ORCL)
Historical Stock Chart
From Apr 2023 to Apr 2024